Ipratropium bromide / salbutamol Azure 0.5 mg / 2.5 mg per 2.5 ml Nebuliser Solution

Licence status
Authorised: 06/03/2026
Active substances
Ipratropium bromide monohydrate, Salbutamol sulfate
Dosage Form
Nebuliser solution
Licence number
PA22871/033/001
Licence holder
Azure Pharmaceuticals Ltd.

Product documents

Licence information

ATC code
R03AL02 salbutamol and ipratropium bromide
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/03/2026